Alzheimer's disease has highest societal cost of any disease in the United States: over $100 billion per year.
 
A+ | A- | Reset
Scientific Advisory Board

Members of the Scientific Advisory Board are invited, independent of the Research Consortium, to provide advice and counsel to the Board of the Cure Alzheimer's Fund regarding the overall scientific soundness of the Research Consortium's approach to scientific discovery (roadmap and other initiatives) and the consistency of grant disbursement policy with criteria approved by the Board for project selection.



Caleb Finch, Ph.D

Photo of Caleb Finch, Ph.DProfessor of Gerontology and Biological Sciences at the University of Southern California.

more>
 
Paul Greengard, Ph.D.

Nobel Prize in Physiology and Medicine, 2000; Head of the Laboratory of Molecular and Cellular Neuroscience; Vincent Astor Professor, The Rockefeller University.

more>
 
John S. Lazo, Ph.D.

Photo of John S. Lazo, Ph.D.Chair, Cure Alzheimer's Fund Scientific Advisory Board
Allegheny Foundation Professor and Director of the Fiske Drug Discovery Laboratory, Department of Pharmacology, University of Pittsburgh School of Medicine and the Co-Director of Molecular Therapeutics/Drug Discovery Program, Pittsburgh Cancer Institute.

more>
 
Marsel Mesulam, M.D.
Dr. Marsel Mesulam is the director of the Cognitive Neurology and Alzheimer’s Disease Center and also serves as the Ruth and Evelyn Dunbar Distinguished Professor at
Northwestern University.
more>